Physician profile
Stephan Barrientos
NPI 1942437397
$7,998.77
in general payments reported to CMS, 2019-2025
23 companies · $2,671 in 2025
The $2,671 reported for 2025 was more than what 88% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $340 · 2021: $552 · 2022: $1,168 · 2023: $1,362 · 2024: $1,905 · 2025: $2,671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,832 · Education: $53.82 · Travel and Lodging: $52.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,832.20 |
| Education | $53.82 |
| Travel and Lodging | $52.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $4,662.08 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Mentor Worldwide LLC | $747.27 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Memoryshape Breast Implant |
| Baxter Healthcare | $468.34 | 2021-2023 | Floseal |
| Musculoskeletal Transplant Foundation INC. | $411.93 | 2022-2025 | |
| Allergan, INC. | $290.96 | 2020-2021 | |
| Acera Surgical, INC. | $273.61 | 2025 | Restrata Wound Matrix |
| Kls-Martin L.P. | $246.90 | 2020-2021 | |
| Acelrx Pharmaceuticals, INC. | $183.55 | 2022 | |
| Abbvie INC. | $175.77 | 2024-2025 | |
| Axogen | $113.75 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Smith+Nephew, INC. | $88.98 | 2022-2023 | Pico 7, Renasys Go V2 Home |
| Acell, INC. | $69.24 | 2020 | |
| Merz North America, INC. | $53.82 | 2023 | |
| Integra Lifesciences Corporation | $40.82 | 2022 | |
| Solventum Corporation | $31.96 | 2025 | Prevena, V.A.C. Granufoam |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $26.81 | 2025 | Xiaflex |
| Kerecis Limited | $21.14 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Mimedx Group, INC. | $19.96 | 2024 | |
| Fujifilm Healthcare Americas Corporation | $16.49 | 2023 | Fujifilm |
| Stryker Corporation | $15.07 | 2020 | |
| Amgen INC. | $13.72 | 2024 | Evenity, Prolia |
| Novo Nordisk INC | $13.42 | 2024 | Wegovy |
| Galderma Laboratories, L.P. | $13.18 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephan Barrientos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.